Company profile EWTX
After 39 days of this quarter the interest is at 94.0. Based on that we can calculate that during remaining 52 days it will total up to 219.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 20 | 80 300.0% QoQ | 228 185.0% QoQ | 43 -81.1% QoQ |
| 2020 | 89 345.0% YoY 107.0% QoQ | 180 125.0% YoY 102.2% QoQ | 94 -58.8% YoY -47.8% QoQ | 119 176.7% YoY 26.6% QoQ |
| 2021 | 289 224.7% YoY 142.9% QoQ | 110 -38.9% YoY -61.9% QoQ | 176 87.2% YoY 60.0% QoQ | 172 44.5% YoY -2.3% QoQ |
| 2022 | 220 -23.9% YoY 27.9% QoQ | 84 -23.6% YoY -61.8% QoQ | 287 63.1% YoY 241.7% QoQ | 217 26.2% YoY -24.4% QoQ |
| 2023 | 184 -16.4% YoY -15.2% QoQ | 166 97.6% YoY -9.8% QoQ | 135 -53.0% YoY -18.7% QoQ | 228 5.1% YoY 68.9% QoQ |
| 2024 | 94 -48.9% YoY -58.8% QoQ | - | - | - |
The average 5 years interest of Edgewise Therapeutics was 12.32 per week. The last year interest of Edgewise Therapeutics compared to the last 5 years has changed by 16.48%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 80.28%.
There is not enough data for EDG-5506 clinical trials to provide analysis
There is not enough data for EDG-5506 clinical trials to provide correlation calculation
There is not enough data for EDG-5506 clinical trials to provide analysis
After 34 days of this quarter the interest is at 67.0. Based on that we can calculate that during remaining 58 days it will total up to 181.0. Duchenne muscular dystrophy treatment expected interest is significantly lower compared to same quarter last year (-45.2%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 283 |
| 2019 | 564 99.3% QoQ | 347 -38.5% QoQ | 256 -26.2% QoQ | 398 40.6% YoY 55.5% QoQ |
| 2020 | 295 -47.7% YoY -25.9% QoQ | 181 -47.8% YoY -38.6% QoQ | 212 -17.2% YoY 17.1% QoQ | 193 -51.5% YoY -9.0% QoQ |
| 2021 | 223 -24.4% YoY 15.5% QoQ | 191 5.5% YoY -14.3% QoQ | 155 -26.9% YoY -18.8% QoQ | 158 -18.1% YoY 1.9% QoQ |
| 2022 | 211 -5.4% YoY 33.5% QoQ | 288 50.8% YoY 36.5% QoQ | 62 -60.0% YoY -78.5% QoQ | 330 108.9% YoY 432.3% QoQ |
| 2023 | 278 31.8% YoY -15.8% QoQ | 267 -7.3% YoY -4.0% QoQ | 255 311.3% YoY -4.5% QoQ | 67 -79.7% YoY -73.7% QoQ |
The average 5 years interest of Duchenne muscular dystrophy treatment was 19.98 per week. The last year interest of Duchenne muscular dystrophy treatment compared to the last 5 years has changed by 6.96%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -29.12%.
There is not enough data for Becker muscular dystrophy treatment to provide analysis
There is not enough data for Becker muscular dystrophy treatment to provide correlation calculation
There is not enough data for Becker muscular dystrophy treatment to provide analysis
There is not enough data for EDG-7500 cardiac disorders to provide analysis
There is not enough data for EDG-7500 cardiac disorders to provide correlation calculation
There is not enough data for EDG-7500 cardiac disorders to provide analysis
Google Trends for Precision medicine for muscle disorders
Not enough data for reliable calculations!
There is not enough data for Precision medicine for muscle disorders to provide analysis
There is not enough data for Precision medicine for muscle disorders to provide correlation calculation
There is not enough data for Precision medicine for muscle disorders to provide analysis
There is not enough data for Edgewise Therapeutics stock price to provide analysis
There is not enough data for Edgewise Therapeutics stock price to provide correlation calculation
There is not enough data for Edgewise Therapeutics stock price to provide analysis
There is not enough data for Edgewise Therapeutics careers to provide analysis
There is not enough data for Edgewise Therapeutics careers to provide correlation calculation
There is not enough data for Edgewise Therapeutics careers to provide analysis
There is not enough data for Edgewise Therapeutics news to provide analysis
There is not enough data for Edgewise Therapeutics news to provide correlation calculation
There is not enough data for Edgewise Therapeutics news to provide analysis
There is not enough data for Edgewise Therapeutics Colorado to provide analysis
There is not enough data for Edgewise Therapeutics Colorado to provide correlation calculation
There is not enough data for Edgewise Therapeutics Colorado to provide analysis